BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37832700)

  • 1. Mucosal absorption of antibody drugs enhanced by cell-penetrating peptides anchored to a platform of polysaccharides.
    Tomono T; Yagi H; Igi R; Tabaru A; Fujimoto K; Enomoto K; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Int J Pharm; 2023 Nov; 647():123499. PubMed ID: 37832700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Cell-Penetrating Peptides Anchored to Polysaccharide Platforms Applied via Various Mucosal Routes as an Absorption Enhancer.
    Yagi H; Tomono T; Handa Y; Saito N; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Mol Pharm; 2023 Jan; 20(1):303-313. PubMed ID: 36484773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
    Tomono T; Yagi H; Ukawa M; Ishizaki S; Miwa T; Nonomura M; Igi R; Kumagai H; Miyata K; Tobita E; Kobayashi H; Sakuma S
    Eur J Pharm Biopharm; 2020 Sep; 154():186-194. PubMed ID: 32681963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.
    Ukawa M; Tanishita S; Yagi H; Yoshida Y; Tomono T; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Mol Pharm; 2019 Mar; 16(3):1105-1118. PubMed ID: 30715891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of absorption-enhancing abilities of cationic oligopeptides with short chain arginine residues through conjugation to hyaluronic acid.
    Tomono T; Yagi H; Kanemoto S; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Int J Pharm; 2022 Mar; 616():121519. PubMed ID: 35093459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Absorption-Enhancing Ability of Oligoarginines Grafted onto a Backbone of Hyaluronic Acid through Animal Studies from Rodents to Primates.
    Yagi H; Tomono T; Abe K; Tsutsumi Y; Makabe M; Mitsuhashi H; Kimura T; Kobayashi H; Miyata K; Shigeno K; Sakuma S
    Mol Pharm; 2024 May; ():. PubMed ID: 38804275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses.
    Tanishita S; Ukawa M; Tomono T; Yoshida Y; Tsujioka T; Miyata K; Tobita E; Uto T; Baba M; Sakuma S
    Bioconjug Chem; 2019 Dec; 30(12):3028-3037. PubMed ID: 31738536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
    Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
    Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery.
    Miyata K; Ukawa M; Mohri K; Fujii K; Yamada M; Tanishita S; Higashitarumi S; Ishizaki S; Kumagai H; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Kobayashi H; Sakuma S
    Bioconjug Chem; 2018 May; 29(5):1748-1755. PubMed ID: 29648441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
    Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
    Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
    Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
    J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligoarginine-linked polymers as a new class of penetration enhancers.
    Sakuma S; Suita M; Masaoka Y; Kataoka M; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Yamashita S
    J Control Release; 2010 Dec; 148(2):187-96. PubMed ID: 20800631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form.
    Iwase Y; Kamei N; Khafagy el-S; Miyamoto M; Takeda-Morishita M
    Int J Pharm; 2016 Aug; 510(1):304-10. PubMed ID: 27343364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
    Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
    Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Penetrating Peptide Penetratin as a Potential Tool for Developing Effective Nasal Vaccination Systems.
    Muto K; Kamei N; Yoshida M; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2016 Jun; 105(6):2014-2017. PubMed ID: 27155764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue.
    Morimoto K; Yamaguchi H; Iwakura Y; Morisaka K; Ohashi Y; Nakai Y
    Pharm Res; 1991 Apr; 8(4):471-4. PubMed ID: 1871041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
    Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism on antigen delivery under mucosal vaccination using cell-penetrating peptides immobilized at multiple points on polymeric platforms.
    Ukawa M; Endo R; Yagi H; Tomono T; Miyata K; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Int J Pharm; 2022 Feb; 613():121376. PubMed ID: 34915143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nose-to-Brain Delivery of Peptide Drugs Enhanced by Coadministration of Cell-penetrating Peptides: Therapeutic Potential for Dementia].
    Kamei N
    Yakugaku Zasshi; 2017; 137(10):1247-1253. PubMed ID: 28966266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.